Needham & Company Downgrades Flexion Therapeutics (FLXN) to Hold Following Takeover

October 12, 2021 3:18 PM EDT
Get Alerts FLXN Hot Sheet
Price: $9.40 +1.08%

Rating Summary:
    12 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 16 | Down: 18 | New: 32
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Needham & Company analyst Serge Belanger downgraded Flexion Therapeutics (NASDAQ: FLXN) from Buy to Hold.

For an analyst ratings summary and ratings history on Flexion Therapeutics click here. For more ratings news on Flexion Therapeutics click here.

Shares of Flexion Therapeutics closed at $9.17 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Needham & Company